133 related articles for article (PubMed ID: 31217077)
21. Molecular inhibition of prostaglandin E2 with GW627368X: Therapeutic potential and preclinical safety assessment in mouse sarcoma model.
Parida S; Parekh A; Dey G; Ghosh SC; Mandal M
Cancer Biol Ther; 2015; 16(6):922-32. PubMed ID: 25894216
[TBL] [Abstract][Full Text] [Related]
22. The prostaglandin EP4 receptor is a master regulator of the expression of PGE
Kashmiry A; Tate R; Rotondo G; Davidson J; Rotondo D
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1297-1304. PubMed ID: 30053598
[TBL] [Abstract][Full Text] [Related]
23. Activation of prostaglandin E2-receptor EP2 and EP4 pathways induces growth inhibition in human gastric carcinoma cell lines.
Okuyama T; Ishihara S; Sato H; Rumi MA; Kawashima K; Miyaoka Y; Suetsugu H; Kazumori H; Cava CF; Kadowaki Y; Fukuda R; Kinoshita Y
J Lab Clin Med; 2002 Aug; 140(2):92-102. PubMed ID: 12228765
[TBL] [Abstract][Full Text] [Related]
24. Prostaglandin E2-stimulated prostanoid EP4 receptors induce prolonged de novo prostaglandin E2 synthesis through biphasic phosphorylation of extracellular signal-regulated kinases mediated by activation of protein kinase A in HCA-7 human colon cancer cells.
Fujino H; Seira N; Kurata N; Araki Y; Nakamura H; Regan JW; Murayama T
Eur J Pharmacol; 2015 Dec; 768():149-59. PubMed ID: 26518053
[TBL] [Abstract][Full Text] [Related]
25. Selective inhibition of prostaglandin E2 receptors EP2 and EP4 modulates DNA methylation and histone modification machinery proteins in human endometriotic cells.
Arosh JA; Lee J; Starzinski-Powitz A; Banu SK
Mol Cell Endocrinol; 2015 Jul; 409():51-8. PubMed ID: 25843056
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of the S1P
Filipenko I; Schwalm S; Reali L; Pfeilschifter J; Fabbro D; Huwiler A; Zangemeister-Wittke U
Biochim Biophys Acta; 2016 Nov; 1861(11):1840-1851. PubMed ID: 27616330
[TBL] [Abstract][Full Text] [Related]
28. CD40 engagement on dendritic cells induces cyclooxygenase-2 and EP2 receptor via p38 and ERK MAPKs.
Harizi H; Limem I; Gualde N
Immunol Cell Biol; 2011 Feb; 89(2):275-82. PubMed ID: 20697426
[TBL] [Abstract][Full Text] [Related]
29. Silymarin suppresses the PGE2 -induced cell migration through inhibition of EP2 activation; G protein-dependent PKA-CREB and G protein-independent Src-STAT3 signal pathways.
Woo SM; Min KJ; Chae IG; Chun KS; Kwon TK
Mol Carcinog; 2015 Mar; 54(3):216-28. PubMed ID: 24127286
[TBL] [Abstract][Full Text] [Related]
30. Prostaglandin E2 receptors EP2 and EP4 are down-regulated in human mononuclear cells after injury.
Strong VE; Winter J; Yan Z; Smyth GP; Mestre JR; Maddali S; Schaefer PA; Yurt RW; Stapleton PP; Daly JM
Surgery; 2001 Aug; 130(2):249-55. PubMed ID: 11490357
[TBL] [Abstract][Full Text] [Related]
31. Prostaglandin E2 stimulates cystogenesis through EP4 receptor in IMCD-3 cells.
Elberg D; Turman MA; Pullen N; Elberg G
Prostaglandins Other Lipid Mediat; 2012 May; 98(1-2):11-6. PubMed ID: 22503965
[TBL] [Abstract][Full Text] [Related]
32. Roles of prostaglandin E2-EP3/EP4 receptor signaling in the enhancement of lymphangiogenesis during fibroblast growth factor-2-induced granulation formation.
Hosono K; Suzuki T; Tamaki H; Sakagami H; Hayashi I; Narumiya S; Alitalo K; Majima M
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1049-58. PubMed ID: 21311040
[TBL] [Abstract][Full Text] [Related]
33. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C
Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627
[TBL] [Abstract][Full Text] [Related]
34. Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists.
Bödder J; Kok LM; Fauerbach JA; Flórez-Grau G; de Vries IJM
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674907
[TBL] [Abstract][Full Text] [Related]
35. Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes.
Aso H; Ito S; Mori A; Suganuma N; Morioka M; Takahara N; Kondo M; Hasegawa Y
Am J Respir Cell Mol Biol; 2013 Mar; 48(3):322-9. PubMed ID: 23221043
[TBL] [Abstract][Full Text] [Related]
36. E prostanoid 2 (EP2)/EP4-mediated suppression of antigen-specific human T-cell responses by prostaglandin E2.
Okano M; Sugata Y; Fujiwara T; Matsumoto R; Nishibori M; Shimizu K; Maeda M; Kimura Y; Kariya S; Hattori H; Yokoyama M; Kino K; Nishizaki K
Immunology; 2006 Jul; 118(3):343-52. PubMed ID: 16827895
[TBL] [Abstract][Full Text] [Related]
37. Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.
Robertson FM; Simeone AM; Mazumdar A; Shah AH; McMurray JS; Ghosh S; Cristofanilli M
J Exp Ther Oncol; 2008; 7(4):299-312. PubMed ID: 19227010
[TBL] [Abstract][Full Text] [Related]
38. Cyclooxygenase-2 up-regulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells.
Pan MR; Hou MF; Chang HC; Hung WC
J Biol Chem; 2008 Apr; 283(17):11155-63. PubMed ID: 18319253
[TBL] [Abstract][Full Text] [Related]
39. EP2 signaling mediates suppressive effects of celecoxib on androgen receptor expression and cell proliferation in prostate cancer.
Kashiwagi E; Shiota M; Yokomizo A; Inokuchi J; Uchiumi T; Naito S
Prostate Cancer Prostatic Dis; 2014 Mar; 17(1):10-7. PubMed ID: 24518515
[TBL] [Abstract][Full Text] [Related]
40. γ-Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K/AKT/mTOR pathway.
Li Y; Wu T; Wang Y; Yang L; Hu C; Chen L; Wu S
Gynecol Oncol; 2018 Apr; 149(1):163-172. PubMed ID: 29429592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
